Division of Dermatology, Department of Medicine, and.
Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada; and.
Blood Adv. 2022 Apr 12;6(7):2334-2345. doi: 10.1182/bloodadvances.2021005884.
Mature T-cell lymphomas (TCLs) are rare, clinically heterogeneous hematologic cancers with high medical need. TCLs have an inferior prognosis which is attributed to poor understanding of their pathogenesis. On the basis of phenotypic similarities between normal and neoplastic lymphocytes, it has been assumed that TCLs develop in the periphery, directly from various subtypes of normal T cells. To address the debated question of the cell of origin in TCLs, we attempted to identify the highly variable complementarity-determining regions (CDRs) of T-cell receptors (TCRs) to trace the clonal history of the T cells. We have collected previously published whole-genome, whole-exome, and whole-transcriptome sequencing data from 574 patients with TCL. TCR clonotypes were identified by de novo assembly of CDR3 regions of TCRα, TCRβ, and TCRγ. We have found that the vast majority of TCLs are clonotypically oligoclonal, although the pattern of oligoclonality varied. Anaplastic large-cell lymphoma was the most diverse comprising multiple clonotypes of TCRα, TCRβ, and TCRγ, whereas adult TCL or leukemia and peripheral TCLs often showed monoclonality for TCRβ and TCRγ but had diverse TCRα clonotypes. These patterns of rearrangements indicated that TCLs are initiated at the level of the lymphoid precursor. In keeping with this hypothesis, TCR rearrangements in TCLs resembled the pattern seen in the human thymus, which showed biased usage of V (variable) and J (joining) segments of high combinatorial probability resulting in recurrent public CDR3 sequences shared across unrelated patients and different clinical TCL entities. Clonotypically diverse initiating cells may seed target tissues that are then responsible for disease relapses after therapy.
成熟 T 细胞淋巴瘤(TCL)是一种罕见的、临床表现多样的血液系统恶性肿瘤,具有较高的医疗需求。TCL 预后较差,这归因于对其发病机制的认识不足。基于正常和肿瘤淋巴细胞之间表型的相似性,人们假设 TCL 在外周直接从各种正常 T 细胞亚类中发展而来。为了解决 TCL 起源细胞的争议问题,我们试图确定 T 细胞受体(TCR)的高度可变互补决定区(CDR),以追踪 T 细胞的克隆历史。我们收集了 574 例 TCL 患者的先前发表的全基因组、全外显子组和全转录组测序数据。通过 TCRα、TCRβ 和 TCRγ 的 CDR3 区域的从头组装来鉴定 TCR 克隆型。我们发现,尽管寡克隆性模式存在差异,但绝大多数 TCL 都是克隆型寡克隆的。间变大细胞淋巴瘤的多样性最大,包含多种 TCRα、TCRβ 和 TCRγ 克隆型,而成人 TCL 或白血病和外周 TCL 通常表现为 TCRβ 和 TCRγ 的单克隆性,但 TCRα 克隆型多样化。这些重排模式表明 TCL 是在淋巴前体细胞水平上启动的。与这一假设一致,TCL 中的 TCR 重排在模式上与人类胸腺相似,后者表现出高组合概率的 V(可变)和 J(连接)片段的偏倚使用,导致在不同的临床 TCL 实体中,不同的无关患者共享的反复出现的公共 CDR3 序列。克隆型多样的起始细胞可能会播种靶组织,然后在治疗后导致疾病复发。